30 Turbo Cancer Treatment race is on: Johnson & Johnson just completed $2 billion cancer drug buy of Ambrx on March 7, 2024 - Merck, Novartis, Sanofi, Eli Lilly, AbbVie, Pfizer, BMS - they all want in! (twitter.com) posted 259 days ago by brain_dead 259 days ago by brain_dead +30 / -0 10 comments share 10 comments share save hide report block hide replies
and now they collect profits on treatment of the cancer caused by the jabs (which they also profited from) they mandated. Double win for evil.
lol, yep